GGrantIndex
Sort

326,823 grants matching clinical trial

Data Management Core

$3,204,138
Sumithra Jay Mandrekar · Mayo Clinic Rochester · U10 · FY2025 · CA

Clinical Studies of Vaccines for Pandemic Influenza

$3,203,625
Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

Discovery and validation of novel targets for pharmacotherapy of alcoholism

$3,203,547
Markus Heilig · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2012 · AA

Leadership for HIV/AIDS Clinical Trials Networks; Microbicide Trials Network

$3,203,442
Benoit Masse · Fred Hutchinson Cancer Research Center · U01 · FY2007 · AI

Yale Alzheimer Disease Research Center

$3,203,339
Stephen M Strittmatter · Yale University · P30 · FY2021 · AG

Gene Expression and Regulatory Networks in Human Leukocytes

$3,203,162
Christophe O Benoist · Harvard Medical School · RC2 · FY2010 · GM

University of Pittsburgh Clinical and Translational Science Institute

$3,203,056
Steven E Reis · University Of Pittsburgh At Pittsburgh · UL1 · FY2016 · TR

The Center for Accelerating Practices to End Suicide through Technology Translation (CAPES)

$3,202,112
Edwin D Boudreaux · Univ Of Massachusetts Med Sch Worcester · P50 · FY2025 · MH

COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER

$3,202,049
Florian Krammer · Icahn School Of Medicine At Mount Sinai · N01 · FY2020 · AI

Investigating Extrachromosomal DNA (ecDNA) Segregation and Repair in Cancer

$3,201,530
Agnel Sfeir · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA

Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy

$3,201,150
Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL

Alzheimer's Disease Research Center

$3,200,598
Scott A Small · Columbia University Health Sciences · P30 · FY2020 · AG

Synthetic DNA & Novel Env Vaccine for HIV

$3,200,000
David B. Weiner · University Of Pennsylvania · U19 · FY2015 · AI

CoVPN 3008 Multi-Center, Randomized, Efficacy Study of Early vs Deferred Vaccination with COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern - LC GY18

$3,200,000
Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2023 · AI

The National Dental PBRN Administrative and Resource Center

$3,200,000
Gregg H Gilbert · University Of Alabama At Birmingham · U19 · FY2019 · DE

Pelvic Floor Disorders Network Data Coordinating Center

$3,200,000
Marie G Gantz · Research Triangle Institute · U24 · FY2022 · HD

A Randomized, Controlled Trial for Homocysteine

$3,200,000
Rhode Island Hospital (Providence, Ri) · U01 · FY2002 · DK

Continuation of Clin Islet Transplantation Consortium: Data Coordinating Center

$3,200,000
William R Clarke · University Of Iowa · U01 · FY2012 · DK

A Randomized, Controlled Trial for Homocysteine

$3,200,000
Rhode Island Hospital (Providence, Ri) · U01 · FY2003 · DK

Optimizing the Immunogenicity of MVA-Based AIDS Vaccines

$3,199,984
Mark B. Feinberg · Emory University · U19 · FY2007 · AI

COMPREHENSIVE RESOURCES FOR HIV MICROBICIDE AND BIOMEDICAL PREVENTION

$3,199,963
James Richardson · Advanced Bioscience Laboratories, Inc. · N01 · FY2014 · AI

Trial to Reduce IDDM in the Genetically at Risk- study

$3,199,795
Hans K Akerblom · University Of Helsinki · U01 · FY2006 · HD

The National Dental PBRN Administrative and Resource Center

$3,199,671
Gregg H Gilbert · University Of Alabama At Birmingham · U19 · FY2020 · DE

Nutrition for Precision Health, powered by the All of Us Research Program: Research Coordinating Center

$3,199,668
Marie G Gantz · Research Triangle Institute · U24 · FY2023 · HD

Dysfunctional lipid metabolism and peroxidation in chronic pain and neurodegeneration

$3,199,356
Christopher Ramsden · National Institute On Aging · ZIA · FY2025 · AG